Compare Appian Corp (APPN) vs ARK Genomic Revolution ETF (ARKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Appian Corp vs ARK Genomic Revolution ETF — how do they compare? Appian Corp trades at $35.5 (market cap $2.54B), while ARK Genomic Revolution ETF trades at $44.88. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Appian Corp nearer its low. Which is the better fit depends on your goals.
| APPN | ARKG | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $45.64 | $44.55 |
52-Week Low | $18.72 | $24.02 |
Enterprise Value | $2.67B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →
